Long term data presented at ESC 2010 shed further light on the benefit of the Cypher Sirolimus Drug-Eluting Stent compared to the Endeavor Zotarolimus-Eluting Stent in important high-risk subgroups
BRIDGEWATER, N.J. - Three new analyses of subgroups from the SORT OUT III study presented at the European Society of Cardiology (ESC) meeting in Stockholm, Sweden, provide additional detail on longer-...
read more
Strong growth in 1st Half of 2010 for Siegfried
ZOFINGEN, Switzerland - With sales of CHF 135.4 million during the first six months of 2010, the Siegfried Group (SIX: SFZN) achieved a 12.4% jump over 2009 (15.4% in local currencies). Active pharmac...
read more
iBio and Fraunhofer execute business development and marketing agreement with GE Healthcare
UPPSALA, Sweden, and NEWARK, Delaware - iBio, Inc. (OTCBB: IBPM), its development collaborator, Fraunhofer USA Center for Molecular Biotechnology (CMB), and GE Healthcare, a unit of General Electric C...
read more
Orasi Medical Inc. partners with Novartis
Orasi Medical Inc. continued its string of impressive partnerships, this time striking a licensing deal with Swiss pharma giant Novartis AG. Novartis, which generated $45.1 billion in sales last year,...
read more
Lonza's L-carnitine may reduce diabetes during pregnancy
Daily supplements of L-carnitine tartrate during pregnancy may decrease levels of free fatty acids linked to insulin resistance and gestational diabetes, says a new study.
read more
Abbott receives FDA approval for first automated molecular test for assessing Hepatitis B treatment
DES PLAINES, Illinois - Abbott (NYSE: ABT) announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or...
read more
Syngenta Seeds introduces new corn hybrids
Syngenta Seeds has introduced 140 new corn hybrids, including 41 featuring the Agrisure Viptera 3111 trait stack, which provides breakthrough control of the broadest spectrum of insects available. The...
read more
U.S. Court of Appeals upholds validity of Lilly's Evista patents through March of 2014
INDIANAPOLIS - Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District...
read more
The ASCO post publishes multiple perspectives on outcome of ODAC meeting regarding Bevacizumab in advanced breast cancer
COLD SPRING HARBOR, N.Y. - The ASCO Post captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be revo...
read more
Analysis: Genzyme units attract interest, what about Sanofi?
NEW YORK/BOSTON - Genzyme Corp (GENZ.O) is entertaining suitors for a small part of its business, even as it seeks a higher offer for the entire company from France's Sanofi-Aventis SA (SASY.PA), whic...
read more
|
